Cargando…

Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection

BACKGROUND: Sequence type 11 (ST11) Klebsiella pneumoniae (Kp) is highly prevalent in China and is a typical sequence type among KPC-producing isolates. This study aimed to evaluate the clinical outcomes and microbiological features of ST11 Kp infections. METHODS: A retrospective cohort study was co...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ping, Wu, Zhenchao, Liu, Chao, Zheng, Jiajia, Wu, Nan, Wu, Zhangli, Yi, Juan, Lu, Ming, Shen, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149164/
https://www.ncbi.nlm.nih.gov/pubmed/35652076
http://dx.doi.org/10.3389/fmed.2022.889020
_version_ 1784717146426703872
author Yang, Ping
Wu, Zhenchao
Liu, Chao
Zheng, Jiajia
Wu, Nan
Wu, Zhangli
Yi, Juan
Lu, Ming
Shen, Ning
author_facet Yang, Ping
Wu, Zhenchao
Liu, Chao
Zheng, Jiajia
Wu, Nan
Wu, Zhangli
Yi, Juan
Lu, Ming
Shen, Ning
author_sort Yang, Ping
collection PubMed
description BACKGROUND: Sequence type 11 (ST11) Klebsiella pneumoniae (Kp) is highly prevalent in China and is a typical sequence type among KPC-producing isolates. This study aimed to evaluate the clinical outcomes and microbiological features of ST11 Kp infections. METHODS: A retrospective cohort study was conducted at Peking University Third Hospital from January 2017 to March 2021. Clinical data were collected from medical records. Antimicrobial susceptibility testing and string tests were performed. Whole-genome sequencing was used to analyze the capsular serotypes, detect virulence-associated genes, and perform multilocus sequence typing. The risk of all-cause mortality in ST11 Kp-infected patients was compared to that in non-ST11 Kp-infected patients. RESULTS: From 139 patients infected with Kp, 49 ST11 Kp (35.3%) strains were isolated. The Charlson comorbidity index in the ST11 group was higher than that in the non-ST11 group (3.94 ± 1.59 vs. 2.41 ± 1.54, P = 0.001). A greater number of ST11 Kp-infected patients required ICU admission (46.9 vs. 16.7%, P < 0.001) and mechanical ventilation (28.6 vs. 10.0%, P = 0.005). All ST11 isolates presented a multidrug-resistant (MDR) phenotype, and twenty-nine (59.2%) hypervirulent Kp (hvKp) were identified. Twenty-four ST11 strains presented with hypermucoviscosity. The presence of capsular types K47 and K64 was frequent in the ST11 Kp strains (P < 0.001). The key virulence-associated genes rmpA, rmpA2, iucA, iroB, and peg344 were present in 26.5, 42.9, 59.2, 0, and 26.5% of the isolates, respectively, in the ST11 group. Twenty-one ST11 isolates harbored the combination of iucA+rmpA2. The 30-day mortality rate and sequential organ failure assessment (SOFA) score were significantly higher in ST11 Kp-infected patients than in non-ST11 Kp-infected patients (P < 0.01). ST11 Kp infection appeared to be an independent risk factor for mortality in ST11 Kp-infected patients. CONCLUSIONS: A high prevalence of the ST11 clone was found in the hospital, which accounted for elevated antimicrobial resistance and exhibited great molecularly inferred virulence. Patients with ST11 Kp infection had a tendency toward increased 30-day mortality and SOFA scores. ST11 Kp infection was an independent risk factor for mortality, suggesting that enhanced surveillance and management are essential.
format Online
Article
Text
id pubmed-9149164
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91491642022-05-31 Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection Yang, Ping Wu, Zhenchao Liu, Chao Zheng, Jiajia Wu, Nan Wu, Zhangli Yi, Juan Lu, Ming Shen, Ning Front Med (Lausanne) Medicine BACKGROUND: Sequence type 11 (ST11) Klebsiella pneumoniae (Kp) is highly prevalent in China and is a typical sequence type among KPC-producing isolates. This study aimed to evaluate the clinical outcomes and microbiological features of ST11 Kp infections. METHODS: A retrospective cohort study was conducted at Peking University Third Hospital from January 2017 to March 2021. Clinical data were collected from medical records. Antimicrobial susceptibility testing and string tests were performed. Whole-genome sequencing was used to analyze the capsular serotypes, detect virulence-associated genes, and perform multilocus sequence typing. The risk of all-cause mortality in ST11 Kp-infected patients was compared to that in non-ST11 Kp-infected patients. RESULTS: From 139 patients infected with Kp, 49 ST11 Kp (35.3%) strains were isolated. The Charlson comorbidity index in the ST11 group was higher than that in the non-ST11 group (3.94 ± 1.59 vs. 2.41 ± 1.54, P = 0.001). A greater number of ST11 Kp-infected patients required ICU admission (46.9 vs. 16.7%, P < 0.001) and mechanical ventilation (28.6 vs. 10.0%, P = 0.005). All ST11 isolates presented a multidrug-resistant (MDR) phenotype, and twenty-nine (59.2%) hypervirulent Kp (hvKp) were identified. Twenty-four ST11 strains presented with hypermucoviscosity. The presence of capsular types K47 and K64 was frequent in the ST11 Kp strains (P < 0.001). The key virulence-associated genes rmpA, rmpA2, iucA, iroB, and peg344 were present in 26.5, 42.9, 59.2, 0, and 26.5% of the isolates, respectively, in the ST11 group. Twenty-one ST11 isolates harbored the combination of iucA+rmpA2. The 30-day mortality rate and sequential organ failure assessment (SOFA) score were significantly higher in ST11 Kp-infected patients than in non-ST11 Kp-infected patients (P < 0.01). ST11 Kp infection appeared to be an independent risk factor for mortality in ST11 Kp-infected patients. CONCLUSIONS: A high prevalence of the ST11 clone was found in the hospital, which accounted for elevated antimicrobial resistance and exhibited great molecularly inferred virulence. Patients with ST11 Kp infection had a tendency toward increased 30-day mortality and SOFA scores. ST11 Kp infection was an independent risk factor for mortality, suggesting that enhanced surveillance and management are essential. Frontiers Media S.A. 2022-05-16 /pmc/articles/PMC9149164/ /pubmed/35652076 http://dx.doi.org/10.3389/fmed.2022.889020 Text en Copyright © 2022 Yang, Wu, Liu, Zheng, Wu, Wu, Yi, Lu and Shen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Yang, Ping
Wu, Zhenchao
Liu, Chao
Zheng, Jiajia
Wu, Nan
Wu, Zhangli
Yi, Juan
Lu, Ming
Shen, Ning
Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title_full Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title_fullStr Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title_full_unstemmed Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title_short Clinical Outcomes and Microbiological Characteristics of Sequence Type 11 Klebsiella pneumoniae Infection
title_sort clinical outcomes and microbiological characteristics of sequence type 11 klebsiella pneumoniae infection
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149164/
https://www.ncbi.nlm.nih.gov/pubmed/35652076
http://dx.doi.org/10.3389/fmed.2022.889020
work_keys_str_mv AT yangping clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT wuzhenchao clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT liuchao clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT zhengjiajia clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT wunan clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT wuzhangli clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT yijuan clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT luming clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection
AT shenning clinicaloutcomesandmicrobiologicalcharacteristicsofsequencetype11klebsiellapneumoniaeinfection